JESSICA MORROW: Open Payments
NPI 1396217634 · NORTH LITTLE ROCK, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$676 in 29 payments from 9 companies in 2025. Trend: 2023 $737 · 2024 $668 · 2025 $676
Food & beverage: $577Education: $99
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 6 | $202 |
| MAYNE PHARMA COMMERCIAL LLC | 11 | $155 |
| Sumitomo Pharma America, Inc. | 4 | $83 |
| Biogen, Inc. | 3 | $77 |
| Minerva Surgical, Inc | 1 | $49 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $36 |
| Organon LLC | 1 | $31 |
| Hologic Sales and Service, LLC | 1 | $24 |
| ABBVIE INC. | 1 | $19 |
Products named: Veozah, MYFEMBREE, ZURZUVAE, Mirena, NEXPLANON, APTIMA, LILETTA.
Industry payments across AR — which companies pay providers there.
